American Association for the Advancement of Science, Science Translational Medicine, 544(12), 2020
DOI: 10.1126/scitranslmed.aaz5629
Full text: Unavailable
The genetically attenuated malaria vaccine PfSPZ-GA1 is safe, immunogenic, and has suboptimal protective efficacy in people.